Integrative single-cell and spatial transcriptomic analyses identify LMX1B as a tumor suppressor orchestrating the GDF15–ATP4B axis in renal cell carcinoma
These findings identify LMX1B as a promising prognostic biomarker and provide multiple druggable nodes for precision therapeutic intervention in renal malignancy.
Abstract
Highlights • Integrative single-cell and spatial transcriptomic analyses identify LMX1B as a previously unrecognized tumor suppressor in renal cell carcinoma.• LMX1B-associated epithelial cells function as central signaling hubs within the tumor microenvironment, engaging in spatially organized bidirectional communication with stromal and immune compartments.• LMX1B transcriptionally activates GDF15 through direct promoter binding, establishing the LMX1B–GDF15–ATP4B axis as a critical tumor-suppressive regulatory cascade.• GDF15 induces mitochondrial apoptosis via ROS-mediated membrane potential depolarization and Bax/Bcl-2-caspase-3 cascade activation in RCC cells.• These findings identify LMX1B as a promising prognostic biomarker and provide multiple druggable nodes for precision therapeutic intervention in renal malignancy.
Integrative single-cell RNA sequencing analysis of publicly available datasets from non-small cell lung cancer and breast cancer is performed to systematically map transcriptional heterogeneity and regulatory networks within the TME, providing a systems-level framework of TME organization.
M. O. Odubote, Chiemeka Elochi Emeribe· bioRxiv· 0 citations
Functional experiments demonstrate that LMO7 silencing decreases clonogenicity and migratory capacity in vitro and suppresses primary tumor growth and metastatic dissemination in vivo, and illustrate how integrating functional, spatial and clinical data can uncover oncogene-driven effectors of metastasis.
Veronika Buršić, Heng Luo, C. Hénon et al.· bioRxiv· 0 citations
This study uncovered previously unrecognized immunosuppressive cell populations and key immune regulators that advance understanding of CRC immune evasion and highlight potential targets for personalized immunotherapy.
Dominika Miroszewska, Shi-Yang Song, Víctor Urbiola-Salvador et al.· British Journal of Cancer· 0 citations
Computational analyses suggest a potential relationship between KIFC1-associated malignant states and tumor microenvironmental signaling, supporting its value as a prognostic biomarker and potential therapeutic target.
Linghan Tian, Yuan-Biao Wang, Li Huang et al.· Molecular Biology Reports· 0 citations
The results demonstrate that S100A10 is significantly upregulated in HCC and is closely associated with poor prognosis and an immunosuppressive state, and provides a theoretical basis for combinatorial strategies targeting metabolism and immunotherapy.
Jing-Xu Zhang, Gang-Gang Wang, Zhijie Zhou et al.· International Immunopharmaco...· 0 citations
This study established an integrative strategy enabling high confidence cell identity assignment in sparse epigenomic data, and revealed the roles of B cell subtypes in the regulation of tumor immunity.
Chen-Yu Wang, Qi-Xin Hu, Jian Chen et al.· The Innovation Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
